Cold & Cough
Natural health product licensed in Canada
- Other names
- Bronchitis Relief, Cold Guard, PelaForce, Upper Respiratory Relief
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80124675
- Status
- Active licence
- Licence date
- 26 May 2023
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Silice, Acide stéarique, Cellulose microcristalline, NA, Stéarate de magnésium, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents et adultes | minimum: 12 years | 1 Capsule | 3 days |
| Enfants | minimum: 6 years ; maximum: 11 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce/relieve the symptoms of upper respiratory tract infections (e.g., common colds). Helps to provide(s) symptomatic relief from/reduce(s) symptom severity of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to relieve(s) symptoms (of cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to reduce the recovery time from/duration of bronchitis, laryngitis, pharyngitis, and/or the common cold (in children, adolescents, and/or adults). Helps to reduce/relieve the symptoms associated with bronchitis and upper respiratory tract infections (e.g., common colds). Helps to reduce/relieve the symptoms (cough, runny nose, sore throat, sputum, and/or chest pain from coughing) associated with upper respiratory tract infections (e.g., common colds).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80124675
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.